Cargando…

SIRT1, Is It a Tumor Promoter or Tumor Suppressor?

SIRT1 has been considered as a tumor promoter because of its increased expression in some types of cancers and its role in inactivating proteins that are involved in tumor suppression and DNA damage repair. However, recent studies demonstrated that SIRT1 levels are reduced in some other types of can...

Descripción completa

Detalles Bibliográficos
Autor principal: Deng, Chu-Xia
Formato: Texto
Lenguaje:English
Publicado: Ivyspring International Publisher 2009
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2631220/
https://www.ncbi.nlm.nih.gov/pubmed/19173036
_version_ 1782163919028092928
author Deng, Chu-Xia
author_facet Deng, Chu-Xia
author_sort Deng, Chu-Xia
collection PubMed
description SIRT1 has been considered as a tumor promoter because of its increased expression in some types of cancers and its role in inactivating proteins that are involved in tumor suppression and DNA damage repair. However, recent studies demonstrated that SIRT1 levels are reduced in some other types of cancers, and that SIRT1 deficiency results in genetic instability and tumorigenesis, while overexpression of SIRT1 attenuates cancer formation in mice heterozygous for tumor suppressor p53 or APC. Here, I review these recent findings and discuss the possibility that activation of SIRT1 both extends lifespan and inhibits cancer formation.
format Text
id pubmed-2631220
institution National Center for Biotechnology Information
language English
publishDate 2009
publisher Ivyspring International Publisher
record_format MEDLINE/PubMed
spelling pubmed-26312202009-01-27 SIRT1, Is It a Tumor Promoter or Tumor Suppressor? Deng, Chu-Xia Int J Biol Sci Review SIRT1 has been considered as a tumor promoter because of its increased expression in some types of cancers and its role in inactivating proteins that are involved in tumor suppression and DNA damage repair. However, recent studies demonstrated that SIRT1 levels are reduced in some other types of cancers, and that SIRT1 deficiency results in genetic instability and tumorigenesis, while overexpression of SIRT1 attenuates cancer formation in mice heterozygous for tumor suppressor p53 or APC. Here, I review these recent findings and discuss the possibility that activation of SIRT1 both extends lifespan and inhibits cancer formation. Ivyspring International Publisher 2009-01-21 /pmc/articles/PMC2631220/ /pubmed/19173036 Text en © Ivyspring International Publisher. This is an open-access article distributed under the terms of the Creative Commons License (http://creativecommons.org/licenses/by-nc-nd/3.0/). Reproduction is permitted for personal, noncommercial use, provided that the article is in whole, unmodified, and properly cited.
spellingShingle Review
Deng, Chu-Xia
SIRT1, Is It a Tumor Promoter or Tumor Suppressor?
title SIRT1, Is It a Tumor Promoter or Tumor Suppressor?
title_full SIRT1, Is It a Tumor Promoter or Tumor Suppressor?
title_fullStr SIRT1, Is It a Tumor Promoter or Tumor Suppressor?
title_full_unstemmed SIRT1, Is It a Tumor Promoter or Tumor Suppressor?
title_short SIRT1, Is It a Tumor Promoter or Tumor Suppressor?
title_sort sirt1, is it a tumor promoter or tumor suppressor?
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2631220/
https://www.ncbi.nlm.nih.gov/pubmed/19173036
work_keys_str_mv AT dengchuxia sirt1isitatumorpromoterortumorsuppressor